Metabolic syndrome and the deadly quartet;Metabolisches Syndrom und todliches Quartett

Internist

Volumn 37, Issue 7, 1996, Pages 698-704

  Standl, E ^a  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SYNDROME; ADULT; AGED; ARTERIOSCLEROSIS; FEMALE; GENETICS; HYPERLIPIDEMIA; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; AGED; ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTORS; SYNDROME;

EID: 0029944070     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Barker DJP, Hales CN, Fall CHD, Osmond C, Philipps K, Clark PMS (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67
2. DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible für NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
3. Denker PS, Pollock VE (1992) Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch Intern Med 152: 1649-1651
4. Dieterle P, Fehm H, Strödter W (1967) Asymptomatischer Diabetes mellitus bei normalgewichtigen Hypertonikern: Dtsch Med Wochenschr 92: 2376-2381
5. Eriksson J, Franssila-Kallunki A, Ekstrand A (1989) Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321: 337-343
6. Eriksson KF, Bengt Saltin, Falke Lindgärde (1994) Increased skeletal muscle capillary density procedes diabetes development in men with impaired glucose tolerance. A 15-year follow up. Diabetes 43: 805-808
7. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico A, Oleggini M, Graziadei L, Pedrinelli T, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
8. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thiboult N, Warnet JM, Claude JR, Rosselin GE (1989) Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32: 300-304
9. Groop L, Ekstrand A, Forsblom C, Widen E, Groop PH, Teppo AM, Eriksson J (1993) Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 642-647
10. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1988) Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319: 1297-1301
11. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992) Prospective analysis of the insulinresistance syndrome (syndrome x). Diabetes 41: 715-722
12. Hales CN (1994) The pathogenesis of NIDDM. Diabetologia 37 [Suppl 2]: 162-168
13. Hanefeld M, Fischer S, Schmechel J, Rothe G, Schulze J, Dude H, Schwanebeck U, Julius U (1991) Diabetes Intervention Study. Multiintervention trial in newly diagnosed NIDDM. Diabetes Care 14: 308-317
14. Hanefeld M, Leonhardt W (1980) Das metabolische Syndrom. Dtsch Gesundheitswesen 36: 715-722
15. Janka HU, Standl E, Stiegler H, Standl R (1994) Angiopathien bei Diabetes mellitus. In: Mehnert H, Schöffling K, Standl E, Usadel KH (Hrsg) Diabetologie in Klinik und Praxis. Thieme, Stuttgart New York, S 418-460
16. Kaplan N (1989) The deadly quartet. Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149: 1514-1520
17. Kuusisto J, Mykkänen, Pyörälä K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43: 960-967
18. Lillioja S (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329: 1988-1992
19. McKeigue PM, Shah B, Marmot MG (1991) Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337: 382-386
20. Muller DC, Elahi D, Pratley RE, Tobin JD, Andres R (1993) An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab 76: 544-548
21. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M (1993) Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36: 553-559
22. Nosadini R, Solini A, Velussi M, Muollo B, Frigato F, Sambataro M, Cipollina MR, De Riva F, Brocco E, Crepoldi G (1993) Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria Diabetes 43: 491-499
23. Pyörälä K, Pedersen TR, Kjekshus J for the Scandinavian Simvastatom Survival Study (4S) Group, Kuopio, Finland, and Oslo, Norway (1995) The effect of cholesterol lowering with simvastatin on coronary events in diabetic patients with coronary heart disease. Diabetes 44 [Suppl 1]:35 A
24. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607
25. Rett K, Wicklmayr E, Standl E (1994) Das metabolische Syndrom. Pathophysiologische Ursachen, Diagnostik und Therapie. Wien Klin Wochenschr 106: 750-757
26. Schnell O, Standl E (1993) Hypertonie und Insulinresistenz. In: Heinen E, Beyer M (Hrsg) Endokrinologie: Hypertonie und Ödeme. pmi, Frankfurt/Main, S 78-83
27. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in den Elderly Program (SHEP). JAMA 265: 3255-3264
28. Stamler J, Vaccaro O, Neaton JD, Wentworth D for the Multiple Risk Factor Intervention Trial Research Group (1993) Diabetes, other risk (actors, and 12-Yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444
29. Standl E, Stiegler H, Janka HU, Mehnert H (1988) Risk profile of macrovascular disease in diabetes mellitus. Diabetes Metab Rev 14: 505-511
30. Standl E, Stiegler H (1993) Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area. Diabetologia 36: 1017-1020
31. Standl E (1995) Hyperinsulinemia and atherosclerosis. Clin Invest Med 18: 261-266
32. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hörmann A (1996) Predictors of 10 year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia (in press)
33. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W (1992) Morbidity, mortality, and albuminuria in type 2 diabetic patients: a 3-year prospective study of a random cohort in general practice. Diabetic Med 9: 646-653
34. Stout RW (1990) Insulin and atheroma - 20-yr perspective. Diabetes Care 13: 631-654
35. Vague J (1956) The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, artherosclerosis gout, and uric calculous disease. Am J Clin Nutr 4: 20-34
36. Zavaroni I, Mazza S, Luchetti L, Buonanno G, Bonati PA, Bergonzani, Passeri M (1990) High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance. Diabetic Med 7: 494-498